Dexamethasone could improve myocardial infarction outcomes and provide new therapeutic options for non-interventional patients

Medical Hypotheses
Joseph Martin Alisky

Abstract

Statins reduce death and morbidity of acute myocardial infarction in part through immunosuppressive mechanisms, suggesting glucocorticoids could produce similar benefits. Glucocorticoids inhibit proliferation of smooth muscle cells and activation of macrophages within atherosclerotic plaques and protect ischemic myocardium through inhibition of a heat shock protein. Dexamethasone-eluting coronary stents have a decreased rate of restenosis, and oral prednisone reduces restenosis of conventional stents. Some studies from the 1970's and 1980's showed that steroids improve survival in myocardial infarction, but no conclusive large-scale randomized well-powered trials have been conducted. Dexamethasone administered alongside statins in the setting of acute myocardial infarction could attenuate myocardial damage in patients with diffuse disease. Patients with acute myocardial infarction who cannot undergo angioplasty or coronary artery bypass grafting could be given a statin and intravenous and oral dexamethasone. Dexamethasone minimizes fluid retention and avoids mineralocorticoid-induced cell proliferation in plaques. Blood glucose monitoring should be ordered for all patients, but diabetic patients need not be excluded. There shou...Continue Reading

References

Oct 1, 1980·Angiology·C A BushH Boudoulas
Dec 12, 2002·Journal of the American College of Cardiology·Francesco VersaciUNKNOWN Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation Study
Apr 26, 2003·The American Journal of Cardiology·Gregory R GiuglianoRichard E Kuntz
Jul 2, 2003·European Heart Journal·G VassalliUNKNOWN Working Group Microcirculation of the Eurpean Society of Cardiology
Oct 9, 2003·Current Rheumatology Reports·Inmaculada del Rincón, Agustín Escalante
Dec 19, 2003·The New England Journal of Medicine·Mary J RomanJane E Salmon
Mar 30, 2005·Scandinavian Journal of Rheumatology·S Wållberg-JonssonS Rantapää-Dahlqvist

❮ Previous
Next ❯

Citations

Jul 14, 2010·Journal of Psychosocial Oncology·Pam McGrath, Hamish Holewa
Nov 7, 2007·European Journal of Endocrinology·Brian R Walker
Feb 26, 2009·British Journal of Pharmacology·Patrick W F HadokeBrian R Walker
Dec 1, 2010·Hormone Molecular Biology and Clinical Investigation·Rongqin Ren, John A Cidlowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.